These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8398301)

  • 1. Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group.
    Jassem J; Karnicka-Młodkowska H; van Pottelsberghe C; van Glabbeke M; Noseda MA; Ardizzoni A; Gozzelino F; Planting A; van Zandwijk N
    Eur J Cancer; 1993; 29A(12):1720-2. PubMed ID: 8398301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Japan Lung Cancer Vinorelbine Study Group.
    Furuse K; Kubota K; Kawahara M; Takada M; Kimura I; Fujii M; Ohta M; Hasegawa K; Yoshida K; Nakajima S; Ogura T; Niitani H
    Oncology; 1996; 53(2):169-72. PubMed ID: 8604245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group.
    Furuse K; Kubota K; Kawahara M; Ogawara M; Kinuwaki E; Motomiya M; Nishiwaki Y; Niitani H; Sakuma A
    Lung Cancer; 1994 Dec; 11(5-6):385-91. PubMed ID: 7704495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinorelbine. A review of its antitumour activity in lung cancer.
    Sørensen JB
    Drugs; 1992; 44 Suppl 4():60-5; discussion 66-9. PubMed ID: 1283851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of intravenous vinorelbine in previously untreated patients with extensive small cell lung cancer, a Southwest Oncology Group study.
    Higano CS; Crowley JJ; Veith RV; Livingston RB
    Invest New Drugs; 1997; 15(2):153-6. PubMed ID: 9220295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II study of Navelbine (vinorelbine) in the treatment of non-small-cell lung cancer.
    Depierre A; Lemarie E; Dabouis G; Garnier G; Jacoulet P; Dalphin JC
    Am J Clin Oncol; 1991 Apr; 14(2):115-9. PubMed ID: 1851385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer: CALGB 9332.
    Johnson E; Lake D; Herndon JE; Box JW; Lynch TJ; Green MR
    Am J Clin Oncol; 2004 Feb; 27(1):19-23. PubMed ID: 14758128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.
    Vokes EE; Rosenberg RK; Jahanzeb M; Craig JB; Gralla RJ; Belani CP; Jones SE; Bigley JW; Hohneker JA
    J Clin Oncol; 1995 Mar; 13(3):637-44. PubMed ID: 7533824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.
    Pronzato P; Landucci M; Vaira F; Vigani A; Bertelli G
    Anticancer Res; 1994; 14(3B):1413-5. PubMed ID: 8067715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine monochemotherapy in non-small-cell lung cancer: experience in patients with low performance status.
    Masotti A; Zannini G; Poggi R; Morandini GC
    Monaldi Arch Chest Dis; 1994 Jun; 49(3):197-200. PubMed ID: 8087113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer.
    Hotta K; Sekine I; Tamura T; Sawada M; Watanabe H; Kusaba H; Akiyama Y; Inoue A; Shimoyama T; Nokihara H; Ueda Y; Yamamoto N; Kunitoh H; Ohe Y; Kodama T; Saijo N
    Jpn J Clin Oncol; 2001 Dec; 31(12):596-600. PubMed ID: 11902490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
    Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
    Crawford J; O'Rourke MA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Morrissey LH; Thomas M; Erland JB; Butts JA; Joseph G; Kalman L; Greco FA
    Cancer J; 2000; 6(3):151-6. PubMed ID: 10882330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.
    Fumoleau P; Delgado FM; Delozier T; Monnier A; Gil Delgado MA; Kerbrat P; Garcia-Giralt E; Keiling R; Namer M; Closon MT
    J Clin Oncol; 1993 Jul; 11(7):1245-52. PubMed ID: 8315421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study.
    Gridelli C; Perrone F; Gallo C; De Marinis F; Ianniello G; Cigolari S; Cariello S; Di Costanzo F; D'Aprile M; Rossi A; Migliorino R; Bartolucci R; Bianco AR; Pergola M; Monfardini S
    Eur J Cancer; 1997 Mar; 33(3):392-7. PubMed ID: 9155522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinorelbine (Navelbine) in the adjuvant and neoadjuvant treatment of non-small cell lung cancer.
    Viallet J; Ayoub J; Rousseau P; Souhami L; Hohneker J; Shepherd F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):64-71; discussion 71-2. PubMed ID: 7973771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.